Our News

Our News

Find out about the latest events and advancements. This summarizes our press releases and latest events information.

2018

Low-Dose Thymoglobulin® Preserves Insulin Production in People Newly Diagnosed With Type 1 Diabetes

Vitiligo Clinical Trial in the News

Lynn Rose, PhD, Promoted to Chief of Scientific Administration

A Potential New Lab Test for Food Allergy

Benaroya Research Institute Scientists Uncover New Strategy for Stopping Breast Cancer

Benaroya Research Institute Receives $5 Million Grant to Explore Personalized Treatments for Peanut Allergy

Margaret McCormick, PhD, Named BRI Chief Administrative Officer

2017

Insulin Pill May Delay Type 1 Diabetes in Some

Chris Amemiya, PhD, Becomes AAAS Fellow

Research discovery could ease lives of allergy sufferers

National Institutes of Health Awards Benaroya Research Institute $3.3 Million to Explore a Potential Cause of Autoimmune Disease

BRI Scientists Discover Cell Involved In All Allergies, Opening Door To New Era Of Allergy And Asthma Research

Type 1 diabetes rates especially high in the Pacific Northwest

Oral insulin therapy fails to prevent type 1 diabetes, but some see disease delay

Benaroya Research Institute Scientists Unveil how a Gene Variation Drives Autoimmune Disease

Pages